Match Document Document Title
US20140343027 EDIBLE OILS TO ENHANCE DELIVERY OF ORALLY ADMINISTERED STEROIDS  
The present invention relates to the formulation of steroids, including neurosteroids (e.g., allopregnanolone (ALP)) in edible oils to enhance their absorption when administered, e.g., orally or...
US20140336131 METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN  
Disclosed herein are methods of treating, reducing, or preventing a disease such as oral mucositis, gastric mucositis, or inflammatory fibrosis, comprising identifying a patient in need of...
US20150259739 DETERMINING AGE RANGES OF SKIN SAMPLES  
The present invention provides methods for characterizing a skin sample of a subject as belonging to an age range by analyzing nucleic acid or protein molecules obtained from the subject. The...
US20120258064 SUBSTANTIALLY ANHYDROUS COMPOSITIONS FOR PERSONAL CARE  
Moisturizers are mixtures of chemicals specifically designed to make the external layers of the skin (epidermis) softer and more pliable, by increasing its hydration (water) content and reducing...
US20110263553 STEROID ANALOGUES FOR NEUROPROTECTION  
Provided are steroid analogues functionalized with polar substituents at the C3 and/or C20 positions of the steroid ring system that exhibit improved water solubility. Also provided are...
US20140148427 NOVEL THERAPY FOR TREATMENT OF CHRONIC DEGENERATIVE BRAIN DISEASES AND NERVOUS SYSTEM INJURY  
In one aspect, the present invention provides neuroactive steroids for use in the treatment of nervous system disorders, degenerative brain diseases and congenital storage diseases. In a second...
US20140011793 NEW STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM, AND METHODS FOR THEIR PRODUCTION  
Steroid compounds having increased resistance against metabolism and increased water solubility are disclosed, together with methods for their production. These substances are suitable for the...
US20140011792 STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM AND METHODS FOR THEIR PRODUCTION  
Steroid compounds having increased resistance against metabolism and increased water solubility are disclosed, together with methods for their production. These substances are suitable for the...
US20130281421 STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM AND METHODS FOR THEIR PRODUCTION  
Steroid compounds having increased resistance against metabolism and increased water solubility are disclosed, together with methods for their production. These substances are suitable for the...
US20130317462 TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS  
A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average...
US20110250274 ESTRIOL FORMULATIONS  
Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of estriol compounds. Embodiments described herein relate to rapidly...
US20110256211 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
US20150110767 METHODS FOR TREATING LUNG INFECTIONS AND INFLAMMATION  
Methods of treating, reducing, or preventing lung infections or lung inflammation include identifying a patient in need of treatment and administering a therapeutically effective amount of at...
US20130172305 Acute Treatment of Social Phobia  
Methods and compositions for the treatment of social phobia are provided, including administering a therapeutically effective amount of an androsta-4,16-dien-3-ol steroid to an individual in need...
US20130224268 TOPICAL DELIVERY OF HORMONAL AND NON HORMONAL NANO FORMULATIONS, METHODS OF MAKING AND USING THE SAME  
The present invention relates to methods for treating, preventing, minimizing, and/or diminishing signs of aging in the skin comprising topically administering to the subject in need thereof a...
US20140309204 STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM  
The present invention relates to steroid hormone products, such as oral contraceptive products, including at least one steroid active ingredient mixed with an excipient and having improved...
US20110046099 STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM  
The present invention relates to steroid hormone products, such as oral contraceptive products, including at least one steroid active ingredient mixed with an excipient and having improved...
US20110046095 STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM  
The present invention relates to steroid hormone products, such as oral contraceptive products, including at least one steroid active ingredient mixed with an excipient and having improved...
US20140274913 METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN  
Compositions and methods for treating, reducing, or preventing a disease or symptom such as gingivitis, periodontitis, gastritis, colitis, ileitis, Crohn's disease, chronic inflammatory intestinal...
US20150259376 NEUROACTIVE 19-ALKOXY-17(20)-Z-VINYLCYANO-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME  
The present disclosure is generally directed to neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for...
US20140235600 NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME  
The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an...
US20150141391 SYSTEMS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION  
The present disclosure relates to methods of determining a treatment course of action. In particular, the present disclosure relates to mutations in the gene encoding estrogen receptor and their...
US20110190201 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject  
A method, device, or kit is provided which maintain a substantially physiological cyclic pre-menopausal level of one or more steroid hormones in a mammalian subject in need thereof. The method,...
US20110256210 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a monthly treatment cycle with a fixed treatment interval and a variable rest interval.
US20130280213 ESTRIOL THERAPY FOR MULTIPLE SCLEROSIS AND OTHER AUTOIMMUNE DISEASES  
The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, more particularly, Th1-mediated (cell-mediated) autoimmune diseases including:...
US20120214778 FULVESTRANT IN A DOSAGE OF 500mg FOR THE TREATMENT OF ADVANCED BREAST CANCER  
The present disclosure is directed to fulvestrant at a dosage of 500 mg and its use in the treatment of a postmenopausal woman with advanced breast cancer.
US20110311442 DIRECT CELLULAR ENERGY DELIVERY SYSTEM  
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group...
US20110288059 NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR  
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder in a subject. Also provided are methods for ameliorating at least one physical symptom or at least one psychological...
US20110183949 Use of Fulvestrant in the Treatment of Resistant Breast Cancer  
The invention relates to the use of fulvestrant in the treatment of breast cancer in patients who have previously been treated with a Selective Estrogen Receptor Modulator (SERM) and an aromatase...
US20140024632 METHODS FOR TREATMENT OF AUTISM SPECTRUM DISORDER  
The present invention relates to the field of autism. More specifically, the present invention provides methods for treating individuals with autism spectrum disorder. Accordingly, in one aspect,...
US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use  
The invention provides methods for decreasing or inhibiting herpesviridae (HV) infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with a...
US20100330086 CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE  
The invention provides methods for decreasing or inhibiting herpesviridae (HV) infection or pathogenesis of a cell in vitro, ex vivo or in vivo, a symptom or pathology associated with a...
US20140200202 USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE  
The present invention relates to a new use of tetrahydroxylated estrogens such as estetrol (1,3,5(10)-estratrien-3,15α,16α,17β-tetrol), namely in a method of emergency contraception. The method of...
US20120171306 THERAPEUTIC TREATMENT OF CANCER AND DYSPLASIA OF THE CERVIX OR VAGINA USING ESTROGEN ANTAGONISTS  
A method for treatment of cervical or vaginal cancer and their associated dysplasia, including the steps of identifying a human cervical or vaginal cancer and/or dysplasia patient, administering...
US20140031327 NON-SURGICAL METHOD OF TREATMENT FOR CATARACT  
The invention provides inhibitors of α-crystallin aggregation and methods of using α-crystallin aggregation inhibitors to, e.g., treat or prevent cataracts in a subject having or at risk of...
US20130261096 Formulation For Hormonotherapy  
The present invention relates to a formulation as a nanoemulsion, comprising a continuous aqueous phase and at least one dispersed phase, and comprising: an amphiphilic lipid,a solubilizing...
US20140370084 ESTRADIOL FORMULATIONS AND THERAPIES  
Estrogen and progesterone replacement therapies are provided herein. Among others, the following formulations are provided herein: solubilized estradiol without progesterone; micronized...
US20140031326 METHODS FOR THE TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME  
The invention relates to methods for the treatment of fibromyalgia and chronic fatigue syndrome by administration of a transdermally applied androgen composition. The treatment is both safe and...
US20110251163 Transdermal Delivery  
Dosing regimen for transdermal delivery of hormones comprising a variable treatment cycle and a variable rest interval.
US20100324006 HORMONE DELIVERY SYSTEM AND METHOD  
A hormone delivery system and method are provided for administering bio identical human hormones using a combination of modalities for the treatment of human physiological conditions.
US20140010806 Treatment of Ocular Diseases  
The invention relates to methods to use 17α-ethynylandrost-5-ene-3β,7β,17β-triol to treat ocular diseases or conditions such as dry eye, uveitis or retinitis. The compound can be administered...
US20140024630 METHOD FOR THE NON-SURGICAL TREATMENT OF LIPODYSTROPHY IN A RETROVIRUS-INFECTED INDIVIDUAL  
The present invention refers to a method for the non-surgical treatment of a lypodistrophy caused by an antiretroviral therapy in an individual infected by a retrovirus, such as HIV, and...
US20150004106 ACNE treatment method  
A topical skin care method for acne and subcutaneous gland disorders utilizing a composition utilizing beta-sitosterol in conjunction with a dermatologically acceptable vehicle such as a lotion,...
US20130210783 NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR  
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder. Also provided are methods for ameliorating at least one symptom resulting from tobacco cessation; and for...
US20120071454 Steroid Compounds and Treatment Methods  
The invention provides methods to treating conditions such as prostate cancer, or for ameliorating one or more symptoms associated with prostate cancer, or for agents that modulate the biological...
US20150246059 NITRATED LIPIDS AND METHODS OF MAKING AND USING THEREOF  
Described herein are nitrated lipids and methods of making and using the nitrated lipids.
US20100331268 Nitrated Lipids and Methods of Making and Using Thereof  
Described herein are nitrated lipids and methods of making and using the nitrated lipids.
US20100310610 COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS  
A transdermal delivery system is provided for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug...
US20140142076 ORAL TRANSMUCOSAL DRUG DELIVERY SYSTEM  
This invention relates to dosage forms for the delivery of drugs across the oral mucosa having improved transmucosal permeability. More specifically, the invention relates to an oral transmucosal...
US20140056848 Method for the Treatment of Multiple Sclerosis  
A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to...